haylaavo

ARL

ARL · NSE · inactive
2.35
+0.10 (+4.44%)
as of 11 May 2012 close
Open
2.35
High
2.45
Low
2.25
Prev close
2.25
52w high
2.70
09 Jun 2011
52w low
1.80
15 Dec 2011
VWAP
2.34
Delivery %
79.5%
of volume
Volume 4.47 L · turnover ₹10.48 L · NSE bhavcopy (official close) · history since 08 Jan 2003
Series
EQ
F&O
No
Status
Inactive since 12 May 2012

Source: NSE equity master · as of 11 May 2012

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 10:59 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
  • 08 May 2012 15:24
    Exchange query

    Members of the Exchange are hereby informed that the trading in equity shares of Arvind Remedies Limited shall be suspended w.e.f. May 14, 2012 (i.e. closing hours of trading on May 11, 2012) on account of Consolidation of equity shares from Re.1/- to Rs.10/-.

  • 12 Mar 2004 24:00
    Exchange query

    Clarification of News : The press had reports on March 11, 2004 that Citiconsult Emerging Markets, a UK based financial institution, will invest $10m in Arvind Remedies Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Arvind Remedies Limited has vide its letter interalia stated, "We wish to inform you that the investment proposal referred to in the press is in the negotiation stage from the last quarter

Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries